Global market research, fieldwork, and respondent recruitment

Global Oncology Treatment Pathway Study

12 markets · Oncologists, nurses & patients

A physician in discussion with a healthcare researcher

Markets

12

Quantitative

1,200 HCP surveys

Qualitative

100 interviews

Audience

Oncologists + nurses + patients

At a glance

Multi-market recruitment of oncologists, oncology nurses and cancer patients for a global pharmaceutical company mapping how targeted oral oncology therapies are selected, sequenced and switched across different healthcare systems.

Audience
Medical, hematology, surgical and radiation oncologists, oncology nurse specialists and hospital pharmacists, with cancer patients and caregivers as a secondary audience.
Markets
USA · Canada · UK · Germany · France · Italy · Spain · Japan · South Korea · China · India · Australia
Methodology
1,200 online HCP surveys plus 60 physician IDIs, 20 oncology-nurse interviews and 20 patient/caregiver interviews.

Understand how oncology treatment decisions are made across different healthcare systems — identifying differences in diagnosis, treatment selection, sequencing, switching behaviour and unmet needs across the major global oncology markets.

What the study explored

  • Patient diagnosis
  • Referral pathways
  • Biomarker testing
  • Treatment selection
  • First- vs later-line therapy
  • Switching behaviour
  • Side-effect management
  • Patient adherence
  • Unmet clinical needs
  • Adoption barriers

Delivered as one coordinated sequence

  1. 01Multi-market feasibility
  2. 02Specialty-specific screening
  3. 03HCP recruitment & validation
  4. 04Patient recruitment
  5. 05Scheduling & fieldwork monitoring
  6. 06Quality control before delivery

Quality controls

Quality controls applied on this project

Only the checks this engagement required — selected by audience, methodology and risk profile.

  1. 01Active-practice and patient-volume screening
  2. 02Specialty and treatment-responsibility validation
  3. 03Patient eligibility checks
  4. 04Centralised multi-market QC

What the research delivered

The study identified significant differences in treatment pathways between markets and highlighted opportunities to improve HCP education, patient support and treatment positioning.

Have a study with similar requirements?

Share your markets, audience, methodology and timeline. Our team will review feasibility and recommend a practical fieldwork approach.

Request Feasibility